| Part Number : NDC25021-0127-20 | Manufacturer : Sagent Pharmaceuticals Inc | ||
| NSN : 6505-01-227-3570 (6505012273570) | |||
| Item Name : Ceftazidime For Injection Usp | CAGE Code : 4RP13 | ||
| NIIN : 01-227-3570 (012273570) | |||
| INC Code : 42844 | |||
| NCB Code : 01 | Country : USA | ||
| Alternate P/N: NDC25021012720 | |||
Thank you for taking an interest in part number NDC25021-0127-20, that of which is listed with the description Ceftazidime For Injection Usp; Manufactured by Sagent Pharmaceuticals Inc and listed alongside the NSN 6505012273570, part number NDC25021-0127-20 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| Part Number : NDC25021-0127-20 | Manufacturer : Sagent Pharmaceuticals Inc | ||
| NSN Number : 6505-01-227-3570 (6505012273570) | |||
| Item Name : Ceftazidime For Injection Usp | CAGE Code : 4RP13 | ||
| NIIN : 012273570 | |||
Thank you for taking an interest in part number NDC25021-0127-20, that of which is listed with the description Ceftazidime For Injection Usp; Manufactured by Sagent Pharmaceuticals Inc and listed alongside the NSN 6505012273570, part number NDC25021-0127-20 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-227-3570 Item PartTypeName: CEFTAZIDIME FOR INJECTION | 6505 | 012273570 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| NDC00409-5082-16 | 5 | 9 | 5 |
| MRC | Criteria | Characteristic |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS CEFTAZIDIME,ANHYDROUS EQUIVALENT |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION 1GM VIAL 25S |
| FEAT | SPECIAL FEATURES | EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME. STORE AT 20-25 DEG C (68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote
